Literature DB >> 27654291

Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.

Richard J P Brown1, Dominic H Banda1, Daniel Todt1, Gabrielle Vieyres1, Eike Steinmann1, Thomas Pietschmann2.   

Abstract

Multiple novel members of the genus Hepacivirus have recently been discovered in diverse mammalian species. However, to date, their replication mechanisms and zoonotic potential have not been explored in detail. The NS3/4A serine protease of hepatitis C virus (HCV) is critical for cleavage of the viral polyprotein. It also cleaves the cellular innate immune adaptor MAVS, thus decreasing interferon (IFN) production and contributing to HCV persistence in the human host. To investigate the conservation of fundamental aspects of the hepaciviral life cycle, we explored if MAVS cleavage and suppression of innate immune signaling represent a common mechanism employed across different clades of the genus Hepacivirus to enhance viral replication. To estimate the zoonotic potential of these nonhuman hepaciviruses, we assessed if their NS3/4A proteases were capable of cleaving human MAVS. NS3/4A proteases of viruses infecting colobus monkeys, rodents, horses, and cows cleaved the MAVS proteins of their cognate hosts and interfered with the ability of MAVS to induce the IFN-β promoter. All NS3/4A proteases from nonhuman viruses readily cleaved human MAVS. Thus, NS3/4A-dependent cleavage of MAVS is a conserved replication strategy across multiple clades within the genus Hepacivirus Human MAVS is susceptible to cleavage by these nonhuman viral proteases, indicating that it does not pose a barrier for zoonotic transmission of these viruses to humans. IMPORTANCE: Virus infection is recognized by cellular sensor proteins triggering innate immune signaling and antiviral defenses. While viruses have evolved strategies to thwart these antiviral programs in their cognate host species, these evasion mechanisms are often ineffective in a novel host, thus limiting viral transmission across species. HCV, the best-characterized member of the genus Hepacivirus within the family Flaviviridae, uses its NS3/4A protease to disrupt innate immune signaling by cleaving the cellular adaptor protein MAVS. Recently, a large number of HCV-related viruses have been discovered in various animal species, including wild, livestock, and companion animals. We show that the NS3/4A proteases of these hepaciviruses from different animals and representing various clades of the genus cleave their cognate host MAVS proteins in addition to human MAVS. Therefore, cleavage of MAVS is a common strategy of hepaciviruses, and human MAVS is likely unable to limit replication of these nonhuman viruses upon zoonotic exposure.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27654291      PMCID: PMC5110154          DOI: 10.1128/JVI.01634-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Characterization of nonprimate hepacivirus and construction of a functional molecular clone.

Authors:  Troels K H Scheel; Amit Kapoor; Eiko Nishiuchi; Kenny V Brock; Yingpu Yu; Linda Andrus; Meigang Gu; Randall W Renshaw; Edward J Dubovi; Sean P McDonough; Gerlinde R Van de Walle; W Ian Lipkin; Thomas J Divers; Bud C Tennant; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 2.  The impact of hepatitis C virus entry on viral tropism.

Authors:  Qiang Ding; Markus von Schaewen; Alexander Ploss
Journal:  Cell Host Microbe       Date:  2014-11-12       Impact factor: 21.023

3.  Serology-enabled discovery of genetically diverse hepaciviruses in a new host.

Authors:  Peter D Burbelo; Edward J Dubovi; Peter Simmonds; Jan L Medina; Jose A Henriquez; Nischay Mishra; Jason Wagner; Rafal Tokarz; John M Cullen; Michael J Iadarola; Charles M Rice; W Ian Lipkin; Amit Kapoor
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

4.  Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.

Authors:  Hiromichi Dansako; Masanori Ikeda; Nobuyuki Kato
Journal:  FEBS J       Date:  2007-07-25       Impact factor: 5.542

5.  Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.

Authors:  Anne Frentzen; Engin Gürlevik; Qinggong Yuan; Eike Steinmann; Michael Ott; Peter Staeheli; Jonathan Schmid-Burgk; Tobias Schmidt; Veit Hornung; Florian Kuehnel; Thomas Pietschmann
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

6.  Emerging pathogens: the epidemiology and evolution of species jumps.

Authors:  Mark E J Woolhouse; Daniel T Haydon; Rustom Antia
Journal:  Trends Ecol Evol       Date:  2005-05       Impact factor: 17.712

7.  How to find simple and accurate rules for viral protease cleavage specificities.

Authors:  Thorsteinn Rögnvaldsson; Terence A Etchells; Liwen You; Daniel Garwicz; Ian Jarman; Paulo J G Lisboa
Journal:  BMC Bioinformatics       Date:  2009-05-16       Impact factor: 3.169

8.  Evidence for novel hepaciviruses in rodents.

Authors:  Jan Felix Drexler; Victor Max Corman; Marcel Alexander Müller; Alexander N Lukashev; Anatoly Gmyl; Bruno Coutard; Alexander Adam; Daniel Ritz; Lonneke M Leijten; Debby van Riel; Rene Kallies; Stefan M Klose; Florian Gloza-Rausch; Tabea Binger; Augustina Annan; Yaw Adu-Sarkodie; Samuel Oppong; Mathieu Bourgarel; Daniel Rupp; Bernd Hoffmann; Mathias Schlegel; Beate M Kümmerer; Detlev H Krüger; Jonas Schmidt-Chanasit; Alvaro Aguilar Setién; Veronika M Cottontail; Thiravat Hemachudha; Supaporn Wacharapluesadee; Klaus Osterrieder; Ralf Bartenschlager; Sonja Matthee; Martin Beer; Thijs Kuiken; Chantal Reusken; Eric M Leroy; Rainer G Ulrich; Christian Drosten
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

9.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Authors:  Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

10.  Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection.

Authors:  Michael G Berg; Deanna Lee; Kelly Coller; Matthew Frankel; Andrew Aronsohn; Kevin Cheng; Kenn Forberg; Marilee Marcinkus; Samia N Naccache; George Dawson; Catherine Brennan; Donald M Jensen; John Hackett; Charles Y Chiu
Journal:  PLoS Pathog       Date:  2015-12-11       Impact factor: 6.823

View more
  16 in total

1.  Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.

Authors:  Raphael Wolfisberg; Kenn Holmbeck; Louise Nielsen; Amit Kapoor; Charles M Rice; Jens Bukh; Troels K H Scheel
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

2.  Immune protection against reinfection with nonprimate hepacivirus.

Authors:  Stephanie Pfaender; Stephanie Walter; Elena Grabski; Daniel Todt; Janina Bruening; Inés Romero-Brey; Theresa Gather; Richard J P Brown; Kerstin Hahn; Christina Puff; Vanessa M Pfankuche; Florian Hansmann; Alexander Postel; Paul Becher; Volker Thiel; Ulrich Kalinke; Bettina Wagner; Ralf Bartenschlager; Wolfgang Baumgärtner; Karsten Feige; Thomas Pietschmann; Jessika M V Cavalleri; Eike Steinmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-08       Impact factor: 11.205

3.  Hepacivirus A Infection in Horses Defines Distinct Envelope Hypervariable Regions and Elucidates Potential Roles of Viral Strain and Adaptive Immune Status in Determining Envelope Diversity and Infection Outcome.

Authors:  Joshua D Ramsay; Ryan Evanoff; Robert H Mealey
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

4.  First identification of bovine hepacivirus in wild boars.

Authors:  Claudio de Martinis; Lorena Cardillo; Claudia Esposito; Maurizio Viscardi; Lorella Barca; Stefania Cavallo; Nicola D'Alessio; Vito Martella; Giovanna Fusco
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

5.  Porcine Sapelovirus 3Cpro Inhibits the Production of Type I Interferon.

Authors:  Mengge Yin; Wei Wen; Haoyuan Wang; Qiongqiong Zhao; Hechao Zhu; Huanchun Chen; Xiangmin Li; Ping Qian
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

6.  Roles of the 5' Untranslated Region of Nonprimate Hepacivirus in Translation Initiation and Viral Replication.

Authors:  Tomohisa Tanaka; Teruhime Otoguro; Atsuya Yamashita; Hirotake Kasai; Takasuke Fukuhara; Yoshiharu Matsuura; Kohji Moriishi
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 7.  Animal Models of Hepatitis C Virus Infection.

Authors:  Alexander Ploss; Amit Kapoor
Journal:  Cold Spring Harb Perspect Med       Date:  2020-05-01       Impact factor: 6.915

Review 8.  The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.

Authors:  Janina Bruening; Bettina Weigel; Gisa Gerold
Journal:  J Immunol Res       Date:  2017-02-01       Impact factor: 4.818

9.  Mass Spectrometry versus Conventional Techniques of Protein Detection: Zika Virus NS3 Protease Activity towards Cellular Proteins.

Authors:  Agnieszka Dabrowska; Aleksandra Milewska; Joanna Ner-Kluza; Piotr Suder; Krzysztof Pyrc
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

10.  NS2 proteases from hepatitis C virus and related hepaciviruses share composite active sites and previously unrecognized intrinsic proteolytic activities.

Authors:  Célia Boukadida; Matthieu Fritz; Brigitte Blumen; Marie-Laure Fogeron; François Penin; Annette Martin
Journal:  PLoS Pathog       Date:  2018-02-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.